Restless legs syndrome - Pathophysiology, diagnosis and treatment

被引:45
|
作者
Satija, Pankaj [1 ]
Ondo, William G. [1 ]
机构
[1] Baylor Coll Med, Dept Neurol, Houston, TX 77030 USA
关键词
D O I
10.2165/00023210-200822060-00004
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Restless legs syndrome (RLS) is clinically defined by the presence of (i) an urge to move the legs with or without an actual paraesthesia; (ii) a worsening of symptoms with inactivity; (iii) improvement with activity; and (iv) a worsening of symptoms in the evening and at night. Patients may use a variety of semantic phrases to describe their symptoms but all must have an urge to move. Most people with RLS also have periodic limb movements during sleep, although this is not part of the clinical diagnostic criteria. RLS is very common. About 10% of all Caucasian populations have RLS, although it may be mild in the majority of cases. Women generally outnumber men by about 2 : 1. As a general rule, RLS severity worsens through the first seven to eight decades of life, but may actually lessen in old age. The aetiology of RLS is only partly understood. There is a strong genetic component, and several genetic linkages and three causative genes have been identified worldwide. Several medical conditions, including renal failure, systemic iron deficiency and pregnancy, and possibly neuropathy, essential tremor and some genetic ataxias, are also associated with high rates of RLS. In all cases to date, the actual CNS pathology of RLS demonstrates reduced iron stores, in a pattern that suggests that the homeostatic control of iron is altered, not just that there is not enough iron entering the brain. The relationship between reduced CNS iron levels and the clinical phenotype or treatment response to dopaminergics is not known but generates promising speculation. Treatment of RLS is usually rewarding. Most patients respond robustly to dopamine receptor agonists. Over time, response may lessen, or the patients may develop 'augmentation', whereby they have a worsening of symptoms, usually in the form of an earlier onset. Other treatment options include gabapentin, or similar antiepileptic drugs, and opioids. High-dose intravenous iron is a promising but still experimental approach.
引用
收藏
页码:497 / 518
页数:22
相关论文
共 50 条
  • [1] Restless legs syndrome. Pathophysiology, diagnosis and treatment
    Castillo-alvarez, Federico
    Marzo-Sola, Maria Eugenia
    MEDICINA CLINICA, 2025, 164 (02): : 84 - 90
  • [2] Restless Legs Syndrome: Pathophysiology and Treatment
    William G. Ondo
    Current Treatment Options in Neurology, 2014, 16
  • [3] Restless Legs Syndrome: Pathophysiology and Treatment
    Ondo, William G.
    CURRENT TREATMENT OPTIONS IN NEUROLOGY, 2014, 16 (11) : 1 - 17
  • [4] Comorbidities, treatment, and pathophysiology in restless legs syndrome
    Trenkwalder, Claudia
    Allen, Richard
    Hoegl, Birgit
    Clemens, Stefan
    Patton, Stephanie
    Schormair, Barbara
    Winkelmann, Juliane
    LANCET NEUROLOGY, 2018, 17 (11): : 994 - 1005
  • [5] Pathophysiology of restless legs syndrome
    Monaca, Christelle
    PRESSE MEDICALE, 2010, 39 (05): : 587 - 591
  • [6] RESTLESS LEGS SYNDROME - DIAGNOSIS AND TREATMENT
    DANEK, A
    POLLMACHER, T
    NERVENARZT, 1990, 61 (02): : 69 - 76
  • [7] Diagnosis and treatment of restless legs syndrome
    Wetter T.C.
    Mitterling T.
    Somnologie, 2016, 20 (4): : 309 - 321
  • [8] Diagnosis and treatment of restless legs syndrome
    Sales, Samantha
    Sanghera, Manjit K.
    Klocko, David J.
    Stewart, R. Malcolm
    JAAPA-JOURNAL OF THE AMERICAN ACADEMY OF PHYSICIAN ASSISTANTS, 2016, 29 (07): : 15 - 20
  • [9] Iron and restless legs syndrome: treatment, genetics and pathophysiology
    Connor, James R.
    Patton, Stephanie M.
    Oexle, Konrad
    Allen, Richard R.
    SLEEP MEDICINE, 2017, 31 : 61 - 70
  • [10] Restless Legs Syndrome: From Pathophysiology to Clinical Diagnosis and Management
    Guo, Shiyi
    Huang, Jinsha
    Jiang, Haiyang
    Han, Chao
    Li, Jie
    Xu, Xiaoyun
    Zhang, Guoxin
    Lin, Zhicheng
    Xiong, Nian
    Wang, Tao
    FRONTIERS IN AGING NEUROSCIENCE, 2017, 9